206 related articles for article (PubMed ID: 36003781)
1. Predicting chemotherapy response in non-small-cell lung cancer
Chang R; Qi S; Zuo Y; Yue Y; Zhang X; Guan Y; Qian W
Front Oncol; 2022; 12():915835. PubMed ID: 36003781
[TBL] [Abstract][Full Text] [Related]
2. Predicting programmed death-ligand 1 expression level in non-small cell lung cancer using a combination of peritumoral and intratumoral radiomic features on computed tomography.
Shiinoki T; Fujimoto K; Kawazoe Y; Yuasa Y; Kajima M; Manabe Y; Ono T; Hirano T; Matsunaga K; Tanaka H
Biomed Phys Eng Express; 2022 Feb; 8(2):. PubMed ID: 35051908
[TBL] [Abstract][Full Text] [Related]
3. An integrated model combined intra- and peritumoral regions for predicting chemoradiation response of non small cell lung cancers based on radiomics and deep learning.
Ma Y; Li Q
Cancer Radiother; 2023 Dec; 27(8):705-711. PubMed ID: 37932182
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Two-Year Recurrence-Free Survival in Operable NSCLC Patients Using Radiomic Features from Intra- and Size-Variant Peri-Tumoral Regions on Chest CT Images.
Lee S; Jung J; Hong H; Kim BS
Diagnostics (Basel); 2022 May; 12(6):. PubMed ID: 35741123
[TBL] [Abstract][Full Text] [Related]
5. MRI-based intratumoral and peritumoral radiomics for preoperative prediction of glioma grade: a multicenter study.
Tan R; Sui C; Wang C; Zhu T
Front Oncol; 2024; 14():1401977. PubMed ID: 38803534
[TBL] [Abstract][Full Text] [Related]
6. Role of intratumoral and peritumoral CT radiomics for the prediction of EGFR gene mutation in primary lung cancer.
Yamazaki M; Yagi T; Tominaga M; Minato K; Ishikawa H
Br J Radiol; 2022 Dec; 95(1140):20220374. PubMed ID: 36115683
[TBL] [Abstract][Full Text] [Related]
7. Deep radiomic model based on the sphere-shell partition for predicting treatment response to chemotherapy in lung cancer.
Chang R; Qi S; Wu Y; Yue Y; Zhang X; Guan Y; Qian W
Transl Oncol; 2023 Sep; 35():101719. PubMed ID: 37320871
[TBL] [Abstract][Full Text] [Related]
8. Combination of Peri- and Intratumoral Radiomic Features on Baseline CT Scans Predicts Response to Chemotherapy in Lung Adenocarcinoma.
Khorrami M; Khunger M; Zagouras A; Patil P; Thawani R; Bera K; Rajiah P; Fu P; Velcheti V; Madabhushi A
Radiol Artif Intell; 2019 Mar; 1(2):e180012. PubMed ID: 32076657
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral and peritumoral radiomics based on dynamic contrast-enhanced MRI for preoperative prediction of intraductal component in invasive breast cancer.
Xu H; Liu J; Chen Z; Wang C; Liu Y; Wang M; Zhou P; Luo H; Ren J
Eur Radiol; 2022 Jul; 32(7):4845-4856. PubMed ID: 35079887
[TBL] [Abstract][Full Text] [Related]
10. Stability and reproducibility of computed tomography radiomic features extracted from peritumoral regions of lung cancer lesions.
Tunali I; Hall LO; Napel S; Cherezov D; Guvenis A; Gillies RJ; Schabath MB
Med Phys; 2019 Nov; 46(11):5075-5085. PubMed ID: 31494946
[TBL] [Abstract][Full Text] [Related]
11. Multiregional radiomic model for breast cancer diagnosis: value of ultrasound-based peritumoral and parenchymal radiomics.
Guo S; Huang X; Xu C; Yu M; Li Y; Wu Z; Zhou A; Xu P
Quant Imaging Med Surg; 2023 May; 13(5):3127-3139. PubMed ID: 37179905
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric MRI-based intratumoral and peritumoral radiomics for predicting the pathological differentiation of hepatocellular carcinoma.
Liu HF; Wang M; Wang Q; Lu Y; Lu YJ; Sheng Y; Xing F; Zhang JL; Yu SN; Xing W
Insights Imaging; 2024 Mar; 15(1):97. PubMed ID: 38536542
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of interim CT-based peritumoral and intratumoral radiomics in laryngeal and hypopharyngeal cancer patients undergoing definitive radiotherapy.
Lin CH; Yan JL; Yap WK; Kang CJ; Chang YC; Tsai TY; Chang KP; Liao CT; Hsu CL; Chou WC; Wang HM; Huang PW; Fan KH; Huang BS; Tung-Chieh Chang J; Tu SJ; Lin CY
Radiother Oncol; 2023 Dec; 189():109938. PubMed ID: 37806562
[TBL] [Abstract][Full Text] [Related]
14. Radiomics model based on intratumoral and peritumoral features for predicting major pathological response in non-small cell lung cancer receiving neoadjuvant immunochemotherapy.
Huang D; Lin C; Jiang Y; Xin E; Xu F; Gan Y; Xu R; Wang F; Zhang H; Lou K; Shi L; Hu H
Front Oncol; 2024; 14():1348678. PubMed ID: 38585004
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral and peritumoral CT-based radiomics strategy reveals distinct subtypes of non-small-cell lung cancer.
Tang X; Huang H; Du P; Wang L; Yin H; Xu X
J Cancer Res Clin Oncol; 2022 Sep; 148(9):2247-2260. PubMed ID: 35430688
[TBL] [Abstract][Full Text] [Related]
16. Predictive Radiomic Models for the Chemotherapy Response in Non-Small-Cell Lung Cancer based on Computerized-Tomography Images.
Chang R; Qi S; Yue Y; Zhang X; Song J; Qian W
Front Oncol; 2021; 11():646190. PubMed ID: 34307127
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the combination of intratumoral and peritumoral radiomic signatures for predicting epidermal growth factor receptor mutation in lung adenocarcinoma.
Kawazoe Y; Shiinoki T; Fujimoto K; Yuasa Y; Hirano T; Matsunaga K; Tanaka H
J Appl Clin Med Phys; 2023 Jun; 24(6):e13980. PubMed ID: 37002910
[TBL] [Abstract][Full Text] [Related]
19. Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas.
Das SK; Fang KW; Xu L; Li B; Zhang X; Yang HF
Sci Rep; 2021 May; 11(1):10829. PubMed ID: 34031529
[TBL] [Abstract][Full Text] [Related]
20. Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT?
Wang X; Zhao X; Li Q; Xia W; Peng Z; Zhang R; Li Q; Jian J; Wang W; Tang Y; Liu S; Gao X
Eur Radiol; 2019 Nov; 29(11):6049-6058. PubMed ID: 30887209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
